da Costa Emmerson C B, Amorim Raquel, da Silva Fernando C, Rocha David R, Papa Michelle P, de Arruda Luciana B, Mohana-Borges Ronaldo, Ferreira Vitor F, Tanuri Amilcar, da Costa Luciana J, Ferreira Sabrina B
Laboratório de Genômica Estrutural, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil.
Universidade Federal do Rio de Janeiro, Departamento de Virologia, Instituto de Microbiologia Paulo de Góes, Rio de Janeiro, Rio de Janeiro, Brazil.
PLoS One. 2013 Dec 20;8(12):e82504. doi: 10.1371/journal.pone.0082504. eCollection 2013.
Dengue virus infection is a serious public health problem in endemic areas of the world where 2.5 billion people live. Clinical manifestations of the Dengue infection range from a mild fever to fatal cases of hemorrhagic fever. Although being the most rapidly spreading mosquito-borne viral infection in the world, until now no strategies are available for effective prevention or control of Dengue infection. In this scenario, the development of compounds that specifically inhibit viral replication with minimal effects to the human hosts will have a substantial effect in minimizing the symptoms of the disease and help to prevent viral transmission in the affected population. The aim of this study was to screen compounds with potential activity against dengue virus from a library of synthetic naphthoquinones. Several 1,2- and 1,4-pyran naphthoquinones were synthesized by a three-component reaction of lawsone, aldehyde (formaldehyde or arylaldehydes) and different dienophiles adequately substituted. These compounds were tested for the ability to inhibit the ATPase activity of the viral NS3 enzyme in in vitro assays and the replication of dengue virus in cultured cells. We have identified two 1,4-pyran naphthoquinones, which inhibited dengue virus replication in mammal cells by 99.0% and three others that reduced the dengue virus ATPase activity of NS3 by two-fold in in vitro assays.
登革病毒感染是一个严重的公共卫生问题,在世界上有25亿人口居住的流行地区。登革热感染的临床表现从轻度发热到致命的出血热病例不等。尽管登革热是世界上传播速度最快的蚊媒病毒感染,但到目前为止,还没有有效的预防或控制登革热感染的策略。在这种情况下,开发对人类宿主影响最小但能特异性抑制病毒复制的化合物,将对减轻疾病症状和帮助预防病毒在受影响人群中的传播产生重大作用。本研究的目的是从合成萘醌库中筛选具有抗登革病毒潜在活性的化合物。通过律草酮、醛(甲醛或芳醛)与充分取代的不同亲双烯体的三组分反应,合成了几种1,2 - 和1,4 - 吡喃萘醌。在体外试验中测试了这些化合物抑制病毒NS3酶ATP酶活性的能力以及它们在培养细胞中对登革病毒复制的影响。我们鉴定出两种1,4 - 吡喃萘醌,它们在哺乳动物细胞中抑制登革病毒复制的能力达99.0%,另外还有三种化合物在体外试验中将登革病毒NS3的ATP酶活性降低了两倍。